Clinical Evidence

Commitment to impactful evidence

The science behind evidence-based care

STARmed supports the generation of high-quality clinical evidence through collaborative research initiatives. We work with clinicians, hospitals, and medical societies to uncover the benefits of STARmed technology while maintaining a patient-centric mindset.

STARmed Thyroid RFA Clinical Evidence

STARmed technology is the most used device by Key Opinion Leaders around the world to develop procedure standards for thyroid RFA. More than 94 articles have been published with STARmed technology to prove the efficacy of STARmed Thyroid RFA in terms of volume reduction rate, symptom relief, cosmetic score, and quality of life.

2022 An international multidisciplinary consensus statement: Radiofrequency ablation and related ultrasound-guided ablation technologies for the treatment of benign and malignant thyroid disease

SEE THE STUDY

2022 Efficacy and Safety of Radiofrequency Ablation of Thyroid Nodules: A Multi-institutional Prospective Cohort Study

SEE THE STUDY

2022 Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy

SEE THE STUDY

2022 Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial

SEE THE STUDY

Endoluminal RFA Clinical Evidence

Endoluminal Radiofrequency ablation (RFA) is a well-established treatment for several benign, premalignant, and malignant disorders with emerging indications and applications for endoluminal RFA. RFA has produced promising outcomes in patients with a variety of biliary and pancreatic indications.

2022 Radiofrequency ablation in the management of primary hepatic and biliary tumors

SEE THE STUDY

2021 Feasibility and Safety of Endoluminal Radiofrequency Ablation as a Rescue Treatment for Bilateral Metal Stent Obstruction Due to Tumor Ingrowth in the Hilum: A Pilot Study

SEE THE STUDY

2021 The Safety of Radiofrequency Ablation Using a Novel Temperature-Controlled Probe for the Treatment of Residual Intraductal Lesions after Endoscopic Papillectomy

SEE THE STUDY

2019 The safety of newly developed automatic temperature- controlled endobiliary radiofrequency ablation system for malignant biliary strictures: A prospective multicenter study

SEE THE STUDY

STARmed Fibroid RFA Clinical Evidence

STARmed technology has been helping patients with fibroid symptoms. We work closely with clinicians, hospitals, and medical societies around the world to ensure the efficacy of our procedure, maintaining a patient-centric mindset.

2022 Efficacy, Complications and Factors Predictive of Response to Treatment with Transvaginal Radiofrequency Ablation for Symptomatic Uterine Myomas

SEE THE STUDY

2020 A Prospective Intervention Trial on Tailored Radiofrequency Ablation of Uterine Myomas

SEE THE STUDY

2019 Transvaginal Radiofrequency Ablation of Myomas: Technique, Outcomes, and Complications

SEE THE STUDY

2018 Ultrasound-guided transvaginal radiofrequency ablation of uterine fibroids assisted by virtual needle tracking system: a preliminary study

SEE THE STUDY